ArticleAntimicrobial agents and chemotherapy2004
Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis.
Article in Antimicrobial agents and chemotherapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Article
- Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease.Pathogens (Basel, Switzerland) · 2023Review
- Peptides to Tackle Leishmaniasis: Current Status and Future Directions.International journal of molecular sciences · 2021Review
- ABC Exporters in Pathogenesis: Role of Synthetic Anti-Microbial Peptides.The protein journal · 2020Article
- Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites.Toxins · 2019Review
- Chlorin, Phthalocyanine, and Porphyrin Types Derivatives in Phototreatment of Cutaneous Manifestations: A Review.International journal of molecular sciences · 2019Review
- Efflux pumps and antimicrobial resistance: Paradoxical components in systems genomics.Progress in biophysics and molecular biology · 2019Review
- Emerging therapeutic targets for treatment of leishmaniasis.Expert opinion on therapeutic targets · 2018Review
- Control of Citrus Post-harvest Green Molds, Blue Molds, and Sour Rot by the Cecropin A-Melittin Hybrid Peptide BP21.Frontiers in microbiology · 2018Article
- Killing of Trypanozoon Parasites by the Equine Cathelicidin eCATH1.Antimicrobial agents and chemotherapy · 2016Article
- Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response.The journal of venomous animals and toxins including tropical diseases · 2016Article
- Antimicrobial peptides.Pharmaceuticals (Basel, Switzerland) · 2013Article
- Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.Antimicrobial agents and chemotherapy · 2012Article
- Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.PloS one · 2012Article
- Anti-trypanosomatid activity of ceragenins.The Journal of parasitology · 2010Article
- Leishmania infection: laboratory diagnosing in the absence of a "gold standard".The American journal of tropical medicine and hygiene · 2010Article
- Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100.Biophysical journal · 2009Article
- Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.Antimicrobial agents and chemotherapy · 2008Article
- Peptide antimicrobial agents.Clinical microbiology reviews · 2006Review
- Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides.Applied and environmental microbiology · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leishmaniases, which are important causes of morbidity and mortality in humans and dogs, are extremely difficult to treat. Antimicrobial peptides are rarely used as alternative treatments for naturally acquired parasitic diseases. Here we report that the acylated synthetic antimicrobial peptide Oct-CA(1-7)M(2-9) is safe and effective for treating naturally acquired canine leishmaniasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.